Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings
CNBC Earnings
Barrons Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

Stocktwits
MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-

Ocular Therapeutix, Inc. | OCUL

Daily Technical Analysis of Ocular Therapeutix, Inc.

Investors didn't show much interest in one Ocular Therapeutix way or another today. It hasn't moved too much today but is slightly down, it lost -0.72% since yesterday.

Currently OCUL isn't at a clear support/resistance line that seems tradable. But let's also consider momentum! Ocular Therapeutix has had a nice run over the last year and provided good returns to shareholders. Over the previous year, the Biotechnology company has grown 188.69 percent which isn't too bad. OCUL might find some support at the 3.87 level, buyers might push the price back up from here. But it's not very clear what will happen.


Last analyzed on 2024-11-13

Analyst Ratings for Ocular Therapeutix By Price Target And Rating

The analysts feel fairly neutral on the prospects for Ocular Therapeutix but a little more positive than negative. The current Analysts Sentiment Score is 22.07. Most companies range between (-200 to 200).

Here's a break down of the latest rating changes. On 2024-04-19 HC Wainwright reiterated their rating of Buy and added a price target of $16.00. JMP Securities reiterated a rating of Market Outperform on 2024-04-16 and added a price target of $24.00. Piper Sandler gave a boost to their price target and moved to $15.00 from $10.00 on 2024-02-26. Bank of America announced that they are initiating coverage with a rating of Buy on 2024-02-09 and added a price target of $15.00. Robert W. Baird announced that they are reiterating a rating of Outperform on 2023-09-14 and provided a price target of $18.00.

Company Ratings Score ?
Composite analyst sentiment score
Positive Ratings Negative Ratings Boost Price Target Lower Price Target
OCUL22.0719.87024.270

Earnings Per Share (EPS) Estimates By Year and Quarter

(updated 2024-04-24)
Company YOY Growth Score (typical -20 to +20) Revision Directions (-6 to +6)
OCUL0.000.00

Short interest for Ocular Therapeutix

We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.

Company Short Score (typical 1-15) ?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
Short Interest Days to Cover Rate of Change Shares Short
OCUL6.25%5.86.27.3264350000

How Ocular Therapeutix compares to the broader Healthcare sector and the more specific Biotechnology industry

Segment Count 1 Day% 5 Day 1 Month 3 Month 6 Month 1 Year RSI 3mo S-momo ? 6mo S-momo 1yr S-momo Resistance ? Support Demark Sell ? Demark Buy Short Interest Analysts Ratings ?
Biotechnology

Show Me Companies With:

S-Momentum: Highest | Lowest
1 Day Growth: Highest | Lowest
5 Day Growth: Highest | Lowest
1 Month Growth: Highest | Lowest
6 Month Growth: Highest | Lowest
94-0.791.401.678.7412.3336.0055.327.466.693.83-13821.22-13102.4117.024.799.387.32
Healthcare

Show Me Companies With:

S-Momentum: Highest | Lowest
1 Day Growth: Highest | Lowest
5 Day Growth: Highest | Lowest
1 Month Growth: Highest | Lowest
6 Month Growth: Highest | Lowest
229-0.461.461.966.149.7026.2653.759.208.748.51-12620.24-12033.0919.004.266.734.83

Social Sentiment for Ocular Therapeutix

Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.

Ticker Social Sentiment(1-10)
OCUL

Companies with the highest correlation to Ocular Therapeutix

Company Score 1 Day% 5 Day 1 Month 3 Month 6 Month 1 Year RSI 3mo S-momo ? 6mo S-momo 1yr S-momo Resistance ? Support Demark Sell ? Demark Buy Short Interest Score
MDGL | Madrigal Pharmaceuticals,0.760.29-5.13-5.3735.5535.3943.92648.7410.727.700.00-23329.50125018.5824
MGNI | Magnite, Inc. Common Stoc0.760.353.3638.0034.9826.65101.52989.8216.5419.660.00-23759.19005.9574
CRSP | CRISPR Therapeutics AG0.74-5.265.963.7514.61-12.51-26.9356-22.71-24.19-28.44-6526.20-3384.340015.3247
MGNX | MacroGenics, Inc.0.73-3.394.85-5.440.14-27.39-57.8153-16.36-40.13-13.77-46467.91-1906.030012.5224

Top 3 correlating companies

See full charts for all peers

Sentiment Score

How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.

Earnings Estimates
Analyst Rating
Price Targets
Short Interest
Financials
Options Sentiment
Institutional Ownership
Social Sentiment
Fidelity Summary
Overall Summary Notes
Calculated Sentiment Sum

Score Sum
(1-45)

/

Average
(1-5)

+

Pattern Rank
(1-5)

=

Total Score
(1-10)

Research

Estimates

SA Earngings
MB Earnings
Yahoo Earnings

Ratings

SA Ratings
MB Ratings
BC Ratings
TR Ratings
Fidelity

Short Interest

MB Shorts
Quandl

Smart Money

MB Institutional
Gurus

Options

BC Options Ratio

Financials

GuruFocus Summary

Social

MB Social
SocialSentiment.com
Twitter
Yahoo
Facebook
Reuters
Google

Misc

Tickeron
Ycharts NAV +/-